EuroCityClinic LLC

1 clinical trials · Sponsor

Record	Firm	Date
Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade (NCT07130032)	EuroCityClinic LLC	2025-08-14

Every clearance here is in the API, with alerts when new ones post.